CS Holdings Co., Ltd. (KRX:000590)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	91,134	72,594	67,389	64,317	73,543	67,692
Market Cap Growth	3.86%	7.72%	4.78%	-12.54%	8.64%	0.85%
Enterprise Value	-45,203	-47,306	-20,111	959	14,353	-4,161
Last Close Price	88500.00	68900.00	61454.03	56734.03	62615.38	57185.34
PE Ratio	2.98	2.34	4.06	4.53	5.01	8.86
PS Ratio	0.67	0.51	0.39	0.37	0.46	0.51
PB Ratio	0.24	0.19	0.19	0.20	0.24	0.23
P/TBV Ratio	0.31	0.25	0.26	0.26	0.32	0.31
P/FCF Ratio	3.94	2.49	2.44	4.03	14.27	29.01
P/OCF Ratio	3.89	2.46	2.39	3.75	9.06	3.48
EV/Sales Ratio	-	-	-	0.01	0.09	-
EV/EBITDA Ratio	-	-	-	0.05	0.62	-
EV/EBIT Ratio	-	-	-	0.06	0.73	-
EV/FCF Ratio	-1.96	-	-	0.06	2.78	-
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.01	0.01
Debt / EBITDA Ratio	0.03	0.04	0.07	0.20	0.17	0.13
Debt / FCF Ratio	0.04	0.03	0.05	0.24	0.79	1.08
Asset Turnover	0.33	0.36	0.46	0.49	0.47	0.41
Inventory Turnover	2.22	2.39	3.01	3.07	3.10	3.32
Quick Ratio	9.88	9.15	7.60	7.09	4.81	8.19
Current Ratio	12.12	11.25	9.41	9.28	6.48	10.01
Return on Equity (ROE)	10.21%	10.45%	6.54%	5.85%	6.93%	4.07%
Return on Assets (ROA)	3.61%	3.50%	3.20%	2.72%	3.62%	3.10%
Return on Capital (ROIC)	3.96%	3.84%	3.50%	3.00%	4.00%	3.37%
Return on Capital Employed (ROCE)	5.90%	5.70%	5.30%	4.60%	6.10%	5.20%
Earnings Yield	33.97%	42.73%	24.60%	22.10%	19.94%	11.28%
FCF Yield	25.37%	40.18%	41.02%	24.84%	7.01%	3.45%
Dividend Yield	0.56%	0.73%	-	-	-	-
Payout Ratio	2.43%	2.43%	7.34%	8.68%	8.76%	17.17%
Buyback Yield / Dilution	4.16%	4.13%	1.82%	2.40%	0.06%	-
Total Shareholder Return	4.72%	4.86%	1.82%	2.40%	0.06%	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.